•
Mar 31, 2020

BioLife Q1 2020 Earnings Report

BioLife Solutions experienced substantial revenue growth, driven by increased demand for biopreservation media and strategic capital investment.

Key Takeaways

BioLife Solutions reported a strong first quarter with a 111% year-over-year increase in total revenue, reaching $12.2 million. The company also secured a $20 million investment from Casdin Capital to bolster its growth strategy.

Total revenue increased by 111% year-over-year, reaching $12.2 million.

Biopreservation media revenue increased by 50% year-over-year and accounted for 71% of total revenue.

The company gained 40 new customers, indicating strong market adoption of its products.

Casdin Capital invested $20 million to accelerate the company's consolidation strategy.

Total Revenue
$12.2M
Previous year: $5.77M
+110.8%
EPS
$0.06
Previous year: $0.02
+200.0%
Gross margin
57.8%
Previous year: 71.5%
-19.2%
Adjusted gross margin
64.1%
Previous year: 71.5%
-10.3%
Adjusted EBITDA
$2.9M
Previous year: $1.4M
+107.1%
Gross Profit
$7.05M
Previous year: $4.12M
+71.0%
Cash and Equivalents
$21.3M
Previous year: $31.8M
-33.2%
Free Cash Flow
$541K
Previous year: $990K
-45.4%
Total Assets
$143M
Previous year: $48.1M
+197.6%

BioLife

BioLife

BioLife Revenue by Segment

Forward Guidance

Due to uncertainty regarding the impact of COVID-19, BioLife withdrew its financial guidance for 2020.

Revenue & Expenses

Visualization of income flow from segment revenue to net income